Scheduled Maintenance Notice
Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.
Select Publications
Journal articles
, 1993, 'Identification of cysteine-containing peptides during the peptide mapping of recombinant proteins', Peptide Research, 6, pp. 242 - 248
, 1993, 'Characterization of a truncated form of recombinant porcine growth hormone generated in vitro during solubilization of inclusion bodies', Protein Expression and Purification, 4, pp. 164 - 175, http://dx.doi.org/10.1006/prep.1993.1023
, 1992, 'Solubilization of growth hormone and other recombinant proteins from Escherichia coli inclusion bodies by using a cationic surfactant.', Biochem J, 285 ( Pt 3), pp. 871 - 879, http://dx.doi.org/10.1042/bj2850871
, 1992, 'A relationship between the starting secondary structure of recombinant porcine growth hormone solubilised from inclusion bodies and the yield of native (monomeric) protein after in vitro refolding', FEBS Letters, 305, pp. 177 - 180, http://dx.doi.org/10.1016/0014-5793(92)80661-y
, 1992, 'Spectrofluorimetric assessment of the surface hydrophobicity of proteins.', Biochem J, 282 ( Pt 2), pp. 589 - 593, http://dx.doi.org/10.1042/bj2820589
, 1991, 'A single step method for the solubilization and refolding of recombinant protein from E. coli inclusion bodies.', Australian Journal of Biotechnology, 5, pp. 78 - 86
Conference Papers
, 2024, '2959 Clinician understanding, acceptance and utilization of ketogenic diet therapy for epilepsy in Australia and New Zealand: a cross-sectional cohort study', BMJ, pp. a5.3 - a5a5, presented at Poster Abstracts, http://dx.doi.org/10.1136/bmjno-2024-anzan.13
, 2017, 'Are we following the status epilepticus guidelines and does it matter?', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000577381503001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2012, 'PRELIMINARY DATA ON THE USE OF MTOR INHIBITORS FOR MANAGEMENT OF REFRACTORY SEIZURES AND FOR THE MANAGEMENT OF SUBEPENDYMAL GIANT CELL ASTROCYTOMAS IN PATIENTS WITH TUBEROUS SCLEROSIS COMPLEX', in EPILEPSIA, WILEY-BLACKWELL, ENGLAND, London, pp. 42 - 42, presented at 10th European Congress on Epileptology, ENGLAND, London, 30 September 2012 - 04 October 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308875900142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2011, 'Arterial Ischaemic Stroke In Children With Heart Disease', in STROKE, LIPPINCOTT WILLIAMS & WILKINS, CA, Los Angeles, pp. E97 - E97, presented at International Stroke Conference, CA, Los Angeles, 08 February 2011 - 10 February 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000287479400193&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 1993, 'SOLUBILIZATION OF GROWTH-HORMONE AND OTHER RECOMBINANT PROTEINS FROM ESCHERICHIA-COLI INCLUSION-BODIES USING A CATIONIC SURFACTANT', in JOURNAL OF CELLULAR BIOCHEMISTRY, WILEY-LISS, pp. 48 - 48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993KN46400156&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Conference Posters
, 2016, 'Myotonic Dystrophy Type 1: Clinical manifestations in children and adolescents', Taiwan, presented at 15th Asian and Oceanic Myology Congress and Taiwanese Child Neurology Society Annual Scientific Meeting, Taiwan
Preprints
, WITHDRAWN: Eligibility for thrombolysis and outcome in pediatric acute ischemic stroke, http://dx.doi.org/10.1101/2024.07.17.24310608